HOME >> MEDICINE >> NEWS
Drug to block mother-to-child HIV transmission induces resistance more often than previously thought

The incidence of drug resistance associated with single-dose nevirapine, a drug used to prevent mother-to-child transmission of HIV-1, may be substantially higher than previously thought and of particular risk for those infected with HIV-1 subtype C, according to three new studies published in the July 1 issue of The Journal of Infectious Diseases, now available online.

A single dose of nevirapine given to an HIV-infected pregnant woman during delivery, and another given to her newborn, can cut the rate of mother-to-child HIV transmission in half. The relative simplicity and affordability of single-dose nevirapine have made it the drug of choice for prevention of mother-to-child transmission in many developing countries.

This new research expands understanding of the risks of drug resistance associated with single-dose nevirapine, but as noted by all three research groups, the clinical implications for patients are not yet clear. More research will be needed to determine whether nevirapine used to prevent mother-to-child transmission affects the chances of successful treatment later with nonnucleoside reverse transcriptase inhibitors, the class of drug to which nevirapine belongs.

Two of the studies analyzed the incidence of nevirapine-associated resistance using laboratory tests more sensitive than standard genotypic assays. In the first, researchers led by Jeffrey A. Johnson, PhD, of the Centers for Disease Control and Prevention, used a new, very sensitive technique to detect resistance mutations in samples of HIV-1 obtained from 50 South African women before and after treatment with single-dose nevirapine. Using a less-sensitive conventional technique called sequence analysis, researchers had previously estimated that viral resistance to nevirapine emerged in approximately 40 percent of women after receiving the single-dose therapy. In contrast, Dr. Johnson and colleagues concluded that resistance emerges in at least 65 percent of women a
'"/>

Contact: Steve Baragona
sbaragona@idsociety.org
703-299-0412
Infectious Diseases Society of America
1-Jun-2005


Page: 1 2 3

Related medicine news :

1. Scientists train nano-building blocks to take on new shapes, as reported in Science
2. Future therapies for stroke may block cell death
3. Scavenger cells may have role blocking obesity, Stanford study shows
4. Computer scientist reveals the math and science behind blockbuster movies
5. First-degree fetal heart block may be reversible
6. MR angiography highly accurate in detecting blocked arteries
7. Scientists stop colon cancer growth in mice by blocking just one enzyme
8. A world first in the treatment of a young patient with a completely blocked yet vital heart artery
9. People often forgo using lifesaving beta blockers despite health insurance
10. Drug could change the standard treatment during procedures to clear blocked arteries
11. Tumor necrosis factor blockers may not cause cancer after all

Post Your Comments:
(Date:3/4/2015)... (PRWEB) March 04, 2015 According to ... millions of people in the U.S. suffer from gastroesophageal ... Medications are commonly prescribed to control acid production, but ... procedures can overly correct the problem and lead to ... Opportunity, GERD occurs when the lower esophageal sphincter does ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 The Conrad ... a total of $6.9 million, which will help ... Niger and Burkina Faso. , The programs cover three ... first will focus on fixing water points in disrepair, ... of local people to maintain water points and ensuring ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 A new ... showing promise in terms of extending life. Studies ... that this new dieting routine can help extend life ... production clearly has long term benefits, many suffering from ... a quicker substitute is necessary. As an alternative to ...
(Date:3/4/2015)... Jose, California (PRWEB) March 04, 2015 ... as chemical preparations for enhancing the appearance of the ... using a wide variety of therapeutic agents to achieve ... lifestyle products in a society obsessed with physical beauty, ... reliant on the production and sales of cosmetics. Growth ...
(Date:3/4/2015)... The defibrillators report provides insights into the growth ... the global market is expected to grow at a ... by 2019. It expects the emerging markets to provide ... established players in the market. , According to the ... at the highest CAGR during the next five years. ...
Breaking Medicine News(10 mins):Health News:New and Proven Acid Reflux Treatments Offer Relief to Millions of Americans 2Health News:New and Proven Acid Reflux Treatments Offer Relief to Millions of Americans 3Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 2Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 3Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 4Health News:Diet Doc Introduces New Alternative to the Feast and Famine Diet 2Health News:Diet Doc Introduces New Alternative to the Feast and Famine Diet 3Health News:Rising Demand for Anti-Aging & Skincare Cosmeceuticals to Drive the Global Cosmetic Chemicals Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Rising Demand for Anti-Aging & Skincare Cosmeceuticals to Drive the Global Cosmetic Chemicals Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Rising Demand for Anti-Aging & Skincare Cosmeceuticals to Drive the Global Cosmetic Chemicals Market, According to a New Report by Global Industry Analysts, Inc. 4Health News:Defibrillators Market worth $12.9 Billion by 2019 with Rise in Aging Population - New Research Report by MarketsandMarkets 2Health News:Defibrillators Market worth $12.9 Billion by 2019 with Rise in Aging Population - New Research Report by MarketsandMarkets 3
(Date:3/4/2015)... 2015 TeraRecon, ( www.terarecon.com ), ... Unternehmen, baut seine Präsenz im EMEA-Markt mit ... of Sales und Stefan Phillips ... Logo - http://photos.prnewswire.com/prnh/20150303/179359LOGO ... den Verkauf und die Geschäftsentwicklung in Europa ...
(Date:3/4/2015)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... on the development of oral drug delivery systems, announced ... 27 th Annual ROTH Conference, taking place March ...  Dr. Michael Berelowitz , Chairman of the ... overview on March 10, 2015.   ...
(Date:3/4/2015)... Company plc (NYSE: PRGO ; TASE) today announced ... will present at the 2015 Barclays Global Healthcare Conference ... Loews Miami Beach Hotel in Miami, FL. ... http://perrigo.investorroom.com/events-webcasts . From its beginnings as a packager ... in Ireland , has grown to become ...
Breaking Medicine Technology:TeraRecon baut seine Präsenz in EMEA aus 2TeraRecon baut seine Präsenz in EMEA aus 3Oramed to Present at the ROTH Conference 2Oramed to Present at the ROTH Conference 3Perrigo Company To Present At The 2015 Barclays Global Healthcare Conference 2
Cached News: